ES8604986A1 - Procedimiento para la preparacion de derivado de esfingosina. - Google Patents

Procedimiento para la preparacion de derivado de esfingosina.

Info

Publication number
ES8604986A1
ES8604986A1 ES538231A ES538231A ES8604986A1 ES 8604986 A1 ES8604986 A1 ES 8604986A1 ES 538231 A ES538231 A ES 538231A ES 538231 A ES538231 A ES 538231A ES 8604986 A1 ES8604986 A1 ES 8604986A1
Authority
ES
Spain
Prior art keywords
compound
iii
reacting
radical
acylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538231A
Other languages
English (en)
Other versions
ES538231A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Switzerland AG
Original Assignee
Solco Basel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6493/83A external-priority patent/CH679209A5/de
Application filed by Solco Basel AG filed Critical Solco Basel AG
Publication of ES8604986A1 publication Critical patent/ES8604986A1/es
Publication of ES538231A0 publication Critical patent/ES538231A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE ESFINGOSINA. COMPRENDE: A) HACER REACCIONAR UN COMPUESTO RACEMICO (II) CON UN REACTIVO ORGANICO CAPAZ DE REACCIONAR CON UN GRUPO HIDROXILICO PRIMARIO PARA OBTENER COMPUESTOS (III); B) ESTEARIFICAR EL COMPUESTO (III) CON UN ACIDO ORGANICO OTICAMENTE ACTIVO; C) SEPARAR EN LOS DIASTEROMEROS DE LA MEZCLA OBTENIDA EN B) LOS COMPUESTOS (V) EN LOS QUE AC2 ES RADICAL ACILICO; D) LIBERAR AL COMPUESTO (V)-D DEL GRUPO PROTECTOR HIDROXILICO R, PARA OBTENER UN COMPUESTO (VIII)-D; E) HACER REACCIONAR EL COMPUESTO (VIII)-D CON EL O-TRIFLUORO N O-TRICLORO-ACETIMIDADO DE UN D-GLUCOSA, PARA OBTENER UN COMPUESTO (XI)-D; Y F) DISOCIAR DE (XI)-D LOS GRUPOS ACILICOS AC2 Y AC4, PARA OBTENER EL COMPUESTO DE FORMULA (I)-D. SIENDO: R1, RADICAL ACILICO DE ACIDO GRASO DE 14 A 24 Y OTROS; R2, RADICAL PENTADECANILICO Y OTROS. RNTENDIENDO POR (II), (II)-D Y (II)-L; POR (III), (III)-D Y (III)-L; Y POR (V), (V)-D Y (V)-L.
ES538231A 1983-12-05 1984-12-04 Procedimiento para la preparacion de derivado de esfingosina. Expired ES8604986A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6493/83A CH679209A5 (en) 1983-12-05 1983-12-05 New neutral glyco-sphingolipid derivs.
CH467184 1984-09-28

Publications (2)

Publication Number Publication Date
ES8604986A1 true ES8604986A1 (es) 1986-03-16
ES538231A0 ES538231A0 (es) 1986-03-16

Family

ID=25696036

Family Applications (2)

Application Number Title Priority Date Filing Date
ES538231A Expired ES8604986A1 (es) 1983-12-05 1984-12-04 Procedimiento para la preparacion de derivado de esfingosina.
ES548901A Expired ES8606373A1 (es) 1983-12-05 1985-11-02 Procedimiento para la preparacion de derivados de esfingosina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES548901A Expired ES8606373A1 (es) 1983-12-05 1985-11-02 Procedimiento para la preparacion de derivados de esfingosina

Country Status (11)

Country Link
US (1) US4952683A (es)
EP (1) EP0146810A3 (es)
AU (1) AU570087B2 (es)
CA (1) CA1259610A (es)
DK (1) DK573384A (es)
ES (2) ES8604986A1 (es)
FI (1) FI844775A7 (es)
HU (1) HU195516B (es)
NO (1) NO844815L (es)
PL (1) PL143901B1 (es)
YU (2) YU202784A (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
US4769362A (en) * 1985-10-01 1988-09-06 Trustees Of Boston University Increased vascular perfusion following administration of lipids
JPH07116209B2 (ja) * 1986-04-11 1995-12-13 メクト株式会社 シアロシルセラミド類及びその製造方法
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
EP0299201A3 (de) * 1987-06-12 1990-08-22 Wilhelm Dr. Hoerrmann Fett-Aminoalkohol enthaltendes Arzneimittel
US5010059A (en) * 1987-06-26 1991-04-23 Solco Basel Ag Pharmaceutical products and lactosyl compounds
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5066496A (en) * 1988-08-03 1991-11-19 Angio-Medical Corporation Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
DE3916072A1 (de) * 1989-05-17 1990-11-22 Thera Ges Fuer Patente Ceramidderivate und ihre verwendung als inhibitoren der sphingolipidsynthese
DE4102817A1 (de) * 1991-01-31 1992-08-06 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von (beta)-fucopyranosyl-phosphaten und sehr reiner gdp-fucose
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (es) * 1992-07-16 1995-11-01 Kirin Brewery
EP0666268B1 (en) * 1992-10-22 2000-04-19 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
EP0694558B1 (en) * 1993-04-15 1999-01-27 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
EP0754053A1 (en) * 1995-02-03 1997-01-22 Korea Institute of Science and Technology Novel hemostatic composition
CA2230738A1 (en) 1997-03-03 1998-09-03 Hiromichi Ohta Production of optically active sphingoid compound
JP4553488B2 (ja) 1998-09-21 2010-09-29 大塚製薬株式会社 カルボキシメチルガラクトース誘導体
US20040180852A1 (en) * 2003-03-10 2004-09-16 Cara-Lynne Schengrund Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus
DE102004025000A1 (de) * 2004-05-21 2005-12-08 Bayer Technology Services Gmbh Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
WO2007112322A2 (en) * 2006-03-28 2007-10-04 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
AU2007269299B2 (en) * 2006-06-30 2013-01-17 Brigham Young University Adjuvants and methods of use
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
JP2010515750A (ja) 2007-01-11 2010-05-13 アラーガン インコーポレイテッド スフィンゴシン−１−ホスフェート（ｓ１ｐ）受容体アンタゴニスト生物活性を有する６−置換インドール−３−カルボン酸アミド化合物
CN101918360A (zh) * 2007-09-24 2010-12-15 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体生物学活性的带芳基或者杂芳基基团的吲哚化合物
US8143291B2 (en) 2008-05-09 2012-03-27 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
BRPI0918399A2 (pt) * 2008-08-12 2015-12-29 Allergan Inc composto antagonista do receptor de esfingosina-1-fosfato (s1p), bem como composição farmacêutica e uso do mesmo
WO2011008475A1 (en) 2009-06-30 2011-01-20 Allergan, Inc. Optionally substituted 2-(arylmethyl, aryloxy or arylthio) -n- pyridin-2 -yl-aryl acetamide or 2, 2-bis (aryl) -n-pyridin-2-yl acetamide compounds as medicaments for the treatment of eye diseases
US8168795B2 (en) * 2009-08-11 2012-05-01 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
WO2011028927A1 (en) 2009-09-04 2011-03-10 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
KR20120087932A (ko) 2009-09-29 2012-08-07 알러간, 인코포레이티드 스핑고신-１-포스페이트-２(ｓ１ｐ２) 수용체의 아형-선택적 조정자로서의 축합 고리 피리딘 화합물
JP5939158B2 (ja) 2009-11-24 2016-06-22 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 治療的有用性を有する受容体調節物質としての新規化合物
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
US8653270B2 (en) 2010-11-22 2014-02-18 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
JP6438417B2 (ja) 2013-03-15 2018-12-12 セレニス セラピューティクス ホールディング エスアー スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
EP4281435A1 (en) 2021-01-25 2023-11-29 Carbocode S.A. Method for the production of d-erythro-sphingosine and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495548A (en) * 1974-04-16 1977-12-21 Tate & Lyle Ltd Sugar derivative containing vinyl groups and copolymers thereof
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals

Also Published As

Publication number Publication date
ES8606373A1 (es) 1986-04-16
FI844775L (fi) 1985-06-06
US4952683A (en) 1990-08-28
PL250710A1 (en) 1985-07-16
PL143901B1 (en) 1988-03-31
HUT36833A (en) 1985-10-28
DK573384A (da) 1985-06-06
DK573384D0 (da) 1984-12-03
EP0146810A2 (de) 1985-07-03
NO844815L (no) 1985-06-06
CA1259610A (en) 1989-09-19
ES538231A0 (es) 1986-03-16
AU570087B2 (en) 1988-03-03
HU195516B (en) 1988-05-30
FI844775A0 (fi) 1984-12-04
YU202784A (en) 1987-02-28
FI844775A7 (fi) 1985-06-06
AU3628684A (en) 1985-06-13
EP0146810A3 (de) 1987-05-13
ES548901A0 (es) 1986-04-16
YU189686A (en) 1987-12-31

Similar Documents

Publication Publication Date Title
ES8604986A1 (es) Procedimiento para la preparacion de derivado de esfingosina.
ES2064310T3 (es) Procedimiento para preparar compuestos de imidazopiridina.
ES8603801A1 (es) Un metodo para preparar derivados de alcanoles aromaticos policiclicos
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
PT96880A (pt) Processo para a preparacao de absorventes triazinicos de luz ultravioleta e de composicoes liquidas que os contem, uteis para a estabilizacao de revestimentos altamente solidos
DK57281A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller syreadditionssalte deraf
MX168414B (es) Composicion de compuestos de separacion mezclas que los contienen, cuerpos elasticos moldeados y procedimiento para su fabricacion
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
HUT57758A (en) Process for producing new sulphonamides consisting of benzene-cyclic or benzene-heterocyclic acids and pharmaceutical preparatives containing said sulphonamides
ES2046671T3 (es) Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-tionas.
SE8604950L (sv) Demensforbettrande och terapeutiska medel
MX168931B (es) Procedimiento para preparar compuestos de organofosforo
PE13799A1 (es) Dihidropironas con actividad antiviral
ES2102870T3 (es) Benzopiranos y composiciones farmaceuticas que los contienen.
ES8105721A1 (es) Un procedimiento para la preparacion de nuevos 1, 2, 4-tria-zoles.
ES8506270A1 (es) Un procedimiento para preparar compuestos analogos de la 7-oxabicicloheptano-prostaglandina
ES8800164A1 (es) Un procedimiento para preparar derivados de imidazolidina
ES498757A0 (es) Procedimiento de preparacion de nuevos derivados del acido ciclopropano-carboxilico
ES8507136A1 (es) Un procedimiento para la preparacion de glicosidos de antraciclina
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
GB881977A (en) Thiophosphonic acid esters
ES520136A0 (es) Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303